Henry Schein, Inc.
HSICHealthcareNASDAQMedical Distribution · Last scanned Jun 2, 2026
Scan Results
Daily timeframeHeadquartered within the healthcare sector, Henry Schein, Inc. focuses on Medical Distribution services and products. Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. The $8.70B market capitalization puts HSIC squarely in mid-cap range for its industry. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments.
Market Cap
$8.70B
Beta
0.82
P/E (TTM)
23.08
P/E (Fwd)
12.93
EPS (TTM)
$3.31
EPS (Fwd)
$5.91
ROE
8.8%
ROA
4.4%
Cash
$138.0M
Total Debt
$3.75B
Free CF
$290.1M
52W Change
8.3%
Annual Financials
Cash vs Debt
The company holds $138.0M in cash, though total debt stands at $3.75B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Annual free cash flow of $290.1M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 8.8%, which is decent for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 4.4% is on the lower side, which is common in asset-heavy industries. Revenue has been relatively flat, moving from $12.65B (2022) to $13.18B (2025).
Henry Schein, Inc. carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Henry Schein, Inc.'s trajectory.